Your browser doesn't support javascript.
loading
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features.
Aloia, Andrea; Petrova, Evgeniya; Tomiuk, Stefan; Bissels, Ute; Déas, Olivier; Saini, Massimo; Zickgraf, Franziska Maria; Wagner, Steve; Spaich, Saskia; Sütterlin, Marc; Schneeweiss, Andreas; Reitberger, Manuel; Rüberg, Silvia; Gerstmayer, Bernhard; Agorku, David; Knöbel, Sebastian; Terranegra, Annalisa; Falleni, Monica; Soldati, Laura; Sprick, Martin Ronald; Trumpp, Andreas; Judde, Jean-Gabriel; Bosio, Andreas; Cairo, Stefano; Hardt, Olaf.
Afiliação
  • Aloia A; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. aloia.andrea@libero.it.
  • Petrova E; XenTech SAS, 4 rue Pierre Fontaine, 91000, Evry, France. epetrova@pasteur.fr.
  • Tomiuk S; Present address: Department of Virology, Pasteur Institute, 25-28 Rue du Docteur Roux, 75015, Paris, France. epetrova@pasteur.fr.
  • Bissels U; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. stefant@miltenyibiotec.de.
  • Déas O; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. ute@miltenyibiotec.de.
  • Saini M; XenTech SAS, 4 rue Pierre Fontaine, 91000, Evry, France. olivier.deas@xentech.eu.
  • Zickgraf FM; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) gGmbH, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. massimo.saini@hi-stem.de.
  • Wagner S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. massimo.saini@hi-stem.de.
  • Spaich S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) gGmbH, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. f.zickgraf@dkfz-heidelberg.de.
  • Sütterlin M; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. f.zickgraf@dkfz-heidelberg.de.
  • Schneeweiss A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) gGmbH, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. steve.wagner@icr.ac.uk.
  • Reitberger M; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. steve.wagner@icr.ac.uk.
  • Rüberg S; Frauenklinik, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. saskia.spaich@umm.de.
  • Gerstmayer B; Frauenklinik, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. marc.suetterlin@umm.de.
  • Agorku D; National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. andreas.schneeweiss@nct-heidelberg.de.
  • Knöbel S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) gGmbH, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. m.reitberger@dkfz-heidelberg.de.
  • Terranegra A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. m.reitberger@dkfz-heidelberg.de.
  • Falleni M; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. silvia@miltenyibiotec.de.
  • Soldati L; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. bernhard@miltenyibiotec.de.
  • Sprick MR; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. davida@miltenyibiotec.de.
  • Trumpp A; Miltenyi Biotec GmbH, Friedrich-Ebert-Strasse 68, 51429, Bergisch Gladbach, Germany. sebastiank@miltenyibiotec.de.
  • Judde JG; Sidra Medical and Research Center, PO Box 26999, Doha, Qatar. aterranegra@sidra.org.
  • Bosio A; Department of Health Sciences, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy. monica.falleni@unimi.it.
  • Cairo S; Department of Health Sciences, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy. laura.soldati@unimi.it.
  • Hardt O; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) gGmbH, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. martin.sprick@hi-stem.de.
Breast Cancer Res ; 17(1): 146, 2015 Nov 25.
Article em En | MEDLINE | ID: mdl-26607327
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Antígenos Embrionários Estágio-Específicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Antígenos Embrionários Estágio-Específicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article